Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women's Health Initiative
- PMID: 23127972
- PMCID: PMC3552067
- DOI: 10.1016/j.ygyno.2012.10.029
Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women's Health Initiative
Abstract
Objective: While low physical activity and high body mass index (BMI) have been associated with higher endometrial cancer incidence, no previous studies have evaluated the association between physical activity and survival after endometrial cancer diagnosis, and studies on BMI and survival have not been performed in a prospective cohort.
Methods: We examined pre-diagnosis BMI and moderate- to vigorous-intensity physical activity in relation to overall and disease-specific survival among 983 postmenopausal women who were diagnosed with endometrial cancer in the Women's Health Initiative Observational Study and Clinical Trials.
Results: Over a median 5.2 (max 14.1) years from diagnosis to death or end of follow-up, 163 total deaths were observed, 66 of which were due to endometrial cancer. We observed a higher all-cause mortality hazard ratio (HR) = 1.85 (95% CI 1.19-2.88) comparing women with a BMI ≥ 35 kg/m(2) to women with BMI< 25 kg/m(2). For endometrial cancer-specific mortality the HR = 2.23 (95% CI 1.09-4.54) comparing extreme BMI categories. To examine histologic subtypes we analyzed type I endometrial tumors separately and found an HR = 1.20 (95% CI 1.07-1.35) associated with all-cause mortality for each 5-unit change in BMI. Moderate- to vigorous-intensity physical activity was not associated with all-cause or endometrial cancer-specific mortality.
Conclusions: Pre-diagnosis BMI, but not physical activity, was associated with survival among women with endometrial cancer. Future studies should investigate mechanisms and timing of BMI onset to better understand the burden of disease attributable to BMI.
Published by Elsevier Inc.
Conflict of interest statement
This work has not been submitted in part or whole for consideration elsewhere and no authors have conflict of interest to report.
No authors have conflict of interest to report.
References
-
- Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114:121–127. - PubMed
-
- von Gruenigen VE, Waggoner SE, Frasure HE, Kavanagh MB, Janata JW, Rose PG, Courneya KS, Lerner E. Lifestyle challenges in endometrial cancer survivorship. Obstet Gynecol. 2011;117:93–100. - PubMed
-
- Anderson B, Connor JP, Andrews JI, Davis CS, Buller RE, Sorosky JI, Benda JA. Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol. 1996;174:1171–8. discussion 1178–9. - PubMed
-
- Everett E, Tamimi H, Greer B, Swisher E, Paley P, Mandel L, Goff B. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol. 2003;90:150–157. - PubMed
Publication types
MeSH terms
Grants and funding
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- T32 CA105666/CA/NCI NIH HHS/United States
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- T32 CA105666T/CA/NCI NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- HHSN268201100001C/WH/WHI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
